BiotechTube
Home/LyGenesis/Paulo Fontes, MD, FACS
PF

Paulo Fontes, MD, FACS

Acting Medical Officer

LyGenesis

Therapeutic Areas

End-Stage Liver DiseaseEnd-Stage Renal DiseaseType 1 DiabetesAging/Immunosenescence

LyGenesis Pipeline

DrugIndicationPhase
Liver Cell TherapyEnd Stage Liver Disease (ESLD)Phase 2A
Thymus Cell TherapyAging/ImmunosenescenceProof of Concept
Kidney Cell TherapyEnd Stage Renal Disease (ESRD)Proof of Concept
Pancreas Cell TherapyType 1 DiabetesProof of Concept

Leadership Team at LyGenesis

MH
Michael Hufford, PhD
Chief Executive Officer
EL
Eric Lagasse, PharmD, PhD
Chief Scientific Officer
JM
Jim Mellon
Chairman of the Board of Directors
View full LyGenesis profile